Michael Ferraresso - Feb 15, 2022 Form 4 Insider Report for AVEO PHARMACEUTICALS, INC. (AVEO)

Role
Chief Commercial Officer
Signature
/s/ Danielle V. Holland, attorney-in-fact
Stock symbol
AVEO
Transactions as of
Feb 15, 2022
Transactions value $
$0
Form type
4
Date filed
2/17/2022, 04:01 PM
Previous filing
Aug 11, 2021
Next filing
Jan 19, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVEO Stock Option (right to buy) Award $0 +220K $0.00 220K Feb 15, 2022 Common Stock 220K $3.67 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest in equal monthly installments from February 15, 2022 through February 15, 2026, subject to the Reporting Person's continued service to the Company.